<DOC>
	<DOCNO>NCT00546039</DOCNO>
	<brief_summary>The purpose study evaluate safety mechanism possible chemopreventive effect synthetic genistein ( BONISTEIN™ ) patient localized prostate cancer undergo laparoscopic radical prostatectomy .</brief_summary>
	<brief_title>Synthetic Genistein ( BONISTEIN™ ) Patients Who Are Undergoing Surgery Prostate Cancer</brief_title>
	<detailed_description>In Norway prostate cancer frequently diagnose cancer male represent second common cause cancer death among men . Epidemiological study show association decrease prostate cancer risk increase soy consumption . Genistein dominate plasma tissue isoflavone soybean product , attribute several anti-cancer effect . BONISTEIN™ novel product , consist &gt; 99,5 % synthetic Genistein aglycone . Chemoprevention ability certain molecule inhibit ( partially totally ) induction progression disease . Our study population consist men diagnose localized prostate cancer agree undergo radical prostatectomy . This provide adequate amount benign , premalignant malignant tissue study effect potential chemopreventive agent biomarkers cell growth differentiation prostatic tissue immunohistochemistry . Prostatic tissue cell also select Lacer Capture Microdissection ( LCM ) analysis semi-quantitative RT-PCR .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>Histological proven prostate cancer clinical stage T1c T2 . Are treated radical prostatectomy 3 6 week consent . Have sign inform consent form . Have previous concurrent hormonal therapy chemotherapy . History previous hormone dependent malignancy . Concomitant thyroid disease currently take thyroid hormone replacement medication . On current high dose soy , micronutrient herbal supplement . On soy vegetarian nutrition extreme dietary habit . On oral anticoagulant . History liver pancreas disease . History hypersensitivity Genistein soy contain product . Have malabsorption condition might interfere absorption investigational product .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Localized prostatectomy</keyword>
	<keyword>Laparoscopic prostatectomy</keyword>
	<keyword>Chemoprevention</keyword>
	<keyword>Genistein</keyword>
	<keyword>BONISTEIN™</keyword>
</DOC>